Your browser is no longer supported. Please, upgrade your browser.
Settings
ILMN Illumina, Inc. daily Stock Chart
ILMN [NASD]
Illumina, Inc.
IndexS&P 500 P/E56.07 EPS (ttm)5.61 Insider Own0.40% Shs Outstand146.84M Perf Week-4.55%
Market Cap46.18B Forward P/E41.83 EPS next Y7.52 Insider Trans-13.57% Shs Float146.53M Perf Month3.56%
Income837.00M PEG2.59 EPS next Q1.36 Inst Own91.90% Short Float1.92% Perf Quarter4.05%
Sales3.33B P/S13.86 EPS this Y-5.10% Inst Trans0.07% Short Ratio2.94 Perf Half Y0.45%
Book/sh25.56 P/B12.31 EPS next Y15.18% ROA13.20% Target Price340.54 Perf Year27.93%
Cash/sh23.92 P/C13.15 EPS next 5Y21.62% ROE24.40% 52W Range226.62 - 372.61 Perf YTD4.86%
Dividend- P/FCF54.59 EPS past 5Y44.40% ROI13.60% 52W High-15.59% Beta1.16
Dividend %- Quick Ratio2.30 Sales past 5Y18.60% Gross Margin69.00% 52W Low38.79% ATR8.72
Employees7300 Current Ratio2.50 Sales Q/Q11.60% Oper. Margin26.50% RSI (14)47.19 Volatility3.40% 2.56%
OptionableYes Debt/Eq0.53 EPS Q/Q-6.20% Profit Margin24.80% Rel Volume0.94 Prev Close322.06
ShortableYes LT Debt/Eq0.24 EarningsApr 25 AMC Payout0.00% Avg Volume956.22K Price314.52
Recom1.90 SMA20-1.58% SMA501.47% SMA200-0.83% Volume907,023 Change-2.34%
Jan-03-19Upgrade UBS Neutral → Buy
Oct-09-18Initiated UBS Neutral
Aug-07-18Upgrade Morgan Stanley Underweight → Equal-Weight
Jul-31-18Reiterated Canaccord Genuity Buy $330 → $340
Feb-05-18Upgrade Citigroup Neutral → Buy
Jan-31-18Upgrade First Analysis Sec Equal-Weight → Overweight $277
Jan-05-18Initiated BTIG Research Neutral
Jan-05-18Downgrade William Blair Outperform → Mkt Perform
Jan-02-18Upgrade Wells Fargo Market Perform → Outperform
Oct-25-17Upgrade Robert W. Baird Neutral → Outperform $184 → $228
Oct-23-17Upgrade Janney Sell → Neutral
Oct-23-17Upgrade Deutsche Bank Hold → Buy $195 → $250
Sep-26-17Resumed Goldman Neutral $200
Aug-07-17Upgrade Canaccord Genuity Hold → Buy $170 → $215
Aug-02-17Upgrade First Analysis Sec Underweight → Equal-Weight
Apr-26-17Reiterated Cantor Fitzgerald Neutral $155 → $170
Mar-20-17Upgrade Leerink Partners Mkt Perform → Outperform
Feb-01-17Reiterated UBS Buy $180 → $185
Jan-18-17Initiated Deutsche Bank Hold $160
Jan-10-17Upgrade BofA/Merrill Neutral → Buy
Apr-24-19 03:01PM  Everything You Need to Know About Investing in Healthcare Motley Fool
Apr-23-19 10:20AM  3 Medical Product Stocks Set to Beat This Earnings Season Zacks
06:00AM  Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect Motley Fool
Apr-20-19 02:00PM  Pump the Brakes on the Illumina and Pacific Biosciences Deal Motley Fool
Apr-19-19 02:48PM  Top Gene-Sequencing Stocks for 2019 Motley Fool
11:02AM  5 Top Healthcare Stocks to Buy in 2019 Motley Fool
10:51AM  Are Insiders Selling Illumina, Inc. (NASDAQ:ILMN) Stock? Simply Wall St.
Apr-18-19 01:24PM  Final trades: Darden, Twitter, Illumina, Motorola & Discretionary CNBC Videos
10:33AM  Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-16-19 07:43PM  3 Top Healthcare Stocks to Buy in April Motley Fool
09:09AM  Will Solid Consumables Drive Illumina's (ILMN) Q1 Earnings? Zacks
Apr-15-19 02:00PM  Four Companies Could Power The New Genomics ETF ETF Trends
Apr-12-19 12:18PM  Get 40% Annualized Returns With This Merger Arbitrage Stock GuruFocus.com
07:23AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Apr-11-19 03:33PM  Biotechnology Market on a Tear: 5 ETFs in Spotlight Zacks
Apr-10-19 04:44PM  Global X Launches GNOM ETF to Tap Booming Genomics Space Zacks
Apr-09-19 04:04PM  Illumina to Announce First Quarter 2019 Financial Results on Thursday, April 25, 2019 Business Wire
03:33PM  These Cannabis and China ETFs are Leading the 2019 Rally Investopedia
11:07AM  Why Vertex Pharmaceuticals Could Conceivably Succeed Too Well Motley Fool
10:42AM  Why Illumina Could Be a Health Tech Powerhouse for Your Portfolio Motley Fool
09:53AM  5 Stocks in the Age of Miracles Motley Fool
Apr-08-19 09:12AM  Medtronic's New Data for HVAD System to Boost CRHF Segment Zacks
Apr-07-19 09:05AM  3 High-Growth Genomics Stocks You Can Buy Motley Fool
Apr-04-19 07:22PM  Final Trades: Illumina, Baidu, Adient & Enterprise Products CNBC Videos
07:21PM  Final Trades: Illumina, Baidu, Adient & Enterprise Products CNBC
08:56AM  Myriad Genetics New Study Data to Lift Prenatal Tests' Uptake Zacks
Apr-03-19 09:10AM  Bio-Rad's Latest FDA Nod to Boost Clinical Diagnostics Arm Zacks
Apr-02-19 08:28AM  Here's Why You Should Invest in Illumina (ILMN) Stock Now Zacks
Apr-01-19 10:27AM  Illumina, Inc.'s (NASDAQ:ILMN) Earnings Grew 14%, Did It Beat Long-Term Trend? Simply Wall St.
Mar-29-19 09:00AM  Illumina Files Patent Infringement Suit Against BGI in Germany Business Wire
Mar-27-19 11:16PM  Were Hedge Funds Right About Fleeing From Illumina, Inc. (ILMN)? Insider Monkey
Mar-26-19 02:00AM  Illumina and the Lundbeck Foundation GeoGenetics Centre Collaborate to Generate One of the Largest Ancient Genome Datasets to Decode the Genetic Origins and Evolution of Mental Health Issues Business Wire
Mar-21-19 04:20PM  Better Buy: Illumina vs. Guardant Health Motley Fool
Mar-20-19 09:30AM  Has Illumina (ILMN) Outpaced Other Medical Stocks This Year? Zacks
Mar-18-19 05:28PM  What's Your DNA Worth? LunaDNA Will Help You Find Out Motley Fool
Mar-17-19 11:33AM  Better Buy: Exact Sciences vs. Illumina Motley Fool
Mar-15-19 05:50PM  Illumina (ILMN) Gains But Lags Market: What You Should Know Zacks
09:30AM  LGND vs. ILMN: Which Stock Should Value Investors Buy Now? Zacks
Mar-12-19 02:10PM  Buy Illumina? What about Schwab? The desk takes your questions CNBC Videos
Mar-11-19 08:56AM  Illumina, Inc. (NASDAQ:ILMN): Will The Growth Last? Simply Wall St.
Mar-10-19 09:11AM  Is Illumina a Buy? Motley Fool
Mar-08-19 08:52AM  Align Technology-Benco Dental Deal to Expand iTero Reach Zacks
Mar-07-19 08:47AM  GNC Holdings to Expand Portfolio With Alani Nutrition Deal Zacks
08:38AM  Tandem's Global Growth a Boost, Operating Losses a Bane Zacks
Mar-06-19 10:48PM  BRIEF-Boai NKY Medical Signs Cooperation Agreement With U.S. Firm Illumina Reuters
09:17AM  Why Illumina Stock Gained 12% in February Motley Fool
08:57AM  GNC Forms Joint Venture With IVC to Improve Cost Efficiency Zacks
Mar-05-19 07:46AM  Here's Why You Must Add Hologic (HOLX) to Your Portfolio Now Zacks
07:42AM  Hologic (HOLX) Receives Global Nods for Omni Hysteroscope Zacks
Mar-04-19 08:31AM  Here's Why You Should Snap Up Abbott (ABT) Stock Right Now Zacks
Feb-28-19 04:05PM  Illumina to Webcast Upcoming Investor Conference Presentation Business Wire
Feb-25-19 08:20AM  Here's Why You Should Invest in Illumina (ILMN) Stock Now Zacks
Feb-23-19 09:15AM  Strong Friday Close Secures a 9th Week in the Green Zacks
Feb-21-19 07:29AM  What Investors Should Know About Illumina, Inc.s (NASDAQ:ILMN) Financial Strength Simply Wall St.
Feb-15-19 01:50PM  Final trades: GE, Royal Caribbean, Illumina, Cisco & Invitation Homes CNBC Videos
Feb-14-19 06:01PM  Stanley Druckenmiller's Top 6 Buys for the 4th Quarter GuruFocus.com
Feb-12-19 03:27PM  Illumina Could Rally to Break Its Downtrend TheStreet.com
11:40AM  The Best S&P 500 Stocks of 2018 Investopedia
10:48AM  Illumina Inc (ILMN) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
10:01AM  Pacific Biosciences (PACB) Incurs Q4 Loss, Revenues Fall Y/Y Zacks
Feb-11-19 05:03PM  The 1 Stock I'd Buy Right Now Motley Fool
Feb-10-19 09:00AM  The $100 Billion Investing Opportunity That Could Revolutionize Cancer Treatment Motley Fool
09:00AM  Health Care Is About to Improve Dramatically; Here's How to Play it TheStreet.com
Feb-08-19 08:00AM  Factors of Influence in 2019, Key Indicators and Opportunity within The Estee Lauder Companies, The New York Times, Twenty-First Century Fox, Kemet, Illumina, and Computer Programs and New Research Emphasizes Economic Growth GlobeNewswire
Feb-06-19 08:55AM  Illumina Names Susan E. Siegel to Its Board of Directors Business Wire
Feb-04-19 01:36PM  Final trades ahead of a big batch of earnings CNBC Videos
Feb-03-19 10:09AM  The Week Ahead In Biotech: Conferences, Clinical Trials, Earnings And IPOs Benzinga
09:00AM  5 Things to Expect From Illumina in 2019 Motley Fool
Feb-01-19 01:42PM  Final trades: Chevron, Illumina, Nvidia & KKR CNBC Videos
07:10AM  Illumina, Inc. (NASDAQ:ILMN): Will The Growth Last? Simply Wall St.
Jan-31-19 09:30AM  CBM or ILMN: Which Is the Better Value Stock Right Now? Zacks
07:13AM  Edited Transcript of ILMN earnings conference call or presentation 29-Jan-19 10:00pm GMT Thomson Reuters StreetEvents
Jan-30-19 05:01PM  What Happened in the Stock Market Today Motley Fool
01:45PM  Illumina Sinks on Fourth-Quarter Earnings Miss TheStreet.com
10:58AM  Morgan Stanley: Illumina's Q1 Guidance Puts 2019 Targets In Question Benzinga
09:58AM  Illumina (ILMN) Q4 Earnings Lag Estimates, Revenues Top Mark Zacks
09:07AM  Illumina Stock Drops, Pandora Rises and Three More Wednesday Morning Movers Barrons.com
08:16AM  Why Illumina's Growth Rate Slowed in the Fourth Quarter -- Temporarily Motley Fool
08:12AM  The Daily Biotech Pulse: Roche Scraps Alzheimer's Disease Trials, Amgen Issues Weak Guidance Benzinga
07:23AM  Dow Jones Futures: Apple, AMD Drive Premarket Rally Investor's Business Daily
04:14AM  Illumina (ILMN) Q4 2018 Earnings Conference Call Transcript Motley Fool
Jan-29-19 05:34PM  Illumina: 4Q Earnings Snapshot Associated Press
05:25PM  Illumina Earnings Mixed, But Stryker Stock Pops On Quarterly Beat Investor's Business Daily
04:05PM  Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2018 Business Wire
11:07AM  Illumina Earnings miss, Revenue beats In Q4 Investing.com
09:54AM  Thermo Fisher (TMO) Down on Business Divestment Declaration Zacks
09:54AM  Here's Why You Should Snap Up Abbott (ABT) Stock Right Now Zacks
07:24AM  Illumina's Q4 Earnings Outlook Benzinga
Jan-28-19 10:12AM  Cerner (CERN) to Report Q4 Earnings: What's in the Cards? Zacks
07:29AM  Will Core Business Units Boost McKesson's (MCK) Q3 Earnings? Zacks
Jan-27-19 06:05PM  3 Top Healthcare Growth Stocks to Buy in 2019 Motley Fool
05:15PM  3 Things You Can Expect From Illumina's Q4 Earnings Update Motley Fool
Jan-25-19 02:41PM  5 Innovation-Led Stocks For The Health Care Boom Investopedia
09:49AM  Will Lower Revenues Dampen Juniper's (JNPR) Q4 Earnings? Zacks
08:53AM  AmerisourceBergen (ABC) Q1 Earnings: What's in the Cards? Zacks
08:24AM  Here's Why You Should Buy Tandem Diabetes (TNDM) Stock Now Zacks
08:12AM  What's in Store for Edwards Lifesciences' (EW) Q4 Earnings? Zacks
Jan-24-19 01:49PM  Will Top-Line Growth Support Corning's (GLW) Q4 Earnings? Zacks
11:41AM  Will GPU Product Introduction Benefit AMD's Q4 Earnings? Zacks
11:15AM  Will Flagship Impella Drive ABIOMED's (ABMD) Q3 Earnings? Zacks
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as enables the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. has a partnership with Lundbeck Foundation GeoGenetics Centre for exploring the relationship between the evolutionary history of select mental and neurological disorders and infectious pathogens. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FLATLEY JAY TDirectorApr 10Sale317.013,3001,046,133331,668Apr 12 04:33 PM
EPSTEIN ROBERT SDirectorApr 01Option Exercise51.171,00051,1704,256Apr 03 05:28 PM
deSouza Francis APresident and CEOApr 01Sale315.933,000947,78873,746Apr 03 05:25 PM
Dadswell CharlesSVP & General CounselApr 01Sale314.4512438,9928,210Apr 03 05:22 PM
EPSTEIN ROBERT SDirectorApr 01Sale314.451,000314,4503,256Apr 03 05:28 PM
FLATLEY JAY TDirectorMar 27Sale306.933,3001,012,869334,968Mar 29 04:01 PM
FLATLEY JAY TDirectorMar 13Sale306.503,3001,011,450338,268Mar 29 04:01 PM
EPSTEIN ROBERT SDirectorMar 01Option Exercise51.171,00051,1704,256Mar 05 04:57 PM
deSouza Francis APresident and CEOMar 01Sale316.513,000949,51876,746Mar 05 04:58 PM
Dadswell CharlesSVP & General CounselMar 01Sale313.931,220382,9958,334Mar 05 04:56 PM
EPSTEIN ROBERT SDirectorMar 01Sale313.931,000313,9303,256Mar 05 04:57 PM
FLATLEY JAY TDirectorFeb 27Sale300.003,300990,000341,568Mar 01 05:23 PM
Hoyt Aimee LSVP, Chief People OfficerFeb 26Sale304.6329890,7802,297Feb 28 05:30 PM
OSTADAN OMEADSVP Mktg, Prod & Strat PlanFeb 15Sale294.621,260371,21629,420Feb 19 07:02 PM
FLATLEY JAY TDirectorFeb 13Sale293.663,300969,078344,868Feb 14 04:21 PM
Van Oene MarkSVP Chief Commercial OfficerFeb 12Option Exercise0.005,639015,419Feb 14 04:36 PM
Ronaghi MostafaSVP & CTOFeb 12Option Exercise0.009,782079,217Feb 14 04:34 PM
RAGUSA ROBERT PSVP, Global Quality & OpsFeb 12Option Exercise0.004,540015,316Feb 14 04:32 PM
OSTADAN OMEADSVP Mktg, Prod & Strat PlanFeb 12Option Exercise0.009,492033,875Feb 14 04:23 PM
FLATLEY JAY TDirectorFeb 12Option Exercise0.0028,8880358,929Feb 14 04:21 PM
deSouza Francis APresident and CEOFeb 12Option Exercise0.0024,621082,910Feb 14 04:17 PM
Dadswell CharlesSVP & General CounselFeb 12Option Exercise0.004,127011,064Feb 14 04:15 PM
EPSTEIN ROBERT SDirectorFeb 01Option Exercise51.171,00051,1704,256Feb 05 04:45 PM
deSouza Francis APresident and CEOFeb 01Sale282.953,000848,85464,104Feb 05 04:46 PM
EPSTEIN ROBERT SDirectorFeb 01Sale280.111,000280,1103,256Feb 05 04:45 PM
Dadswell CharlesSVP & General CounselFeb 01Sale280.1112434,7346,879Feb 05 04:44 PM
FLATLEY JAY TDirectorJan 23Sale303.533,3001,001,649329,979Jan 25 04:27 PM
FLATLEY JAY TDirectorJan 09Sale296.203,300977,460333,279Jan 11 04:35 PM
EASTHAM KARINDirectorJan 02Option Exercise71.094,000284,36015,838Jan 04 05:03 PM
EPSTEIN ROBERT SDirectorJan 02Option Exercise51.171,00051,1704,256Jan 04 05:05 PM
EPSTEIN ROBERT SDirectorJan 02Sale294.711,000294,7103,256Jan 04 05:05 PM
deSouza Francis APresident and CEOJan 02Sale293.333,000879,99467,104Jan 04 05:04 PM
EASTHAM KARINDirectorJan 02Sale294.085,0001,470,38110,838Jan 04 05:03 PM
Dadswell CharlesSr VP & General CounselJan 02Sale294.7112436,5447,003Jan 04 05:01 PM
FLATLEY JAY TDirectorDec 26Sale273.873,300903,771336,579Dec 28 05:36 PM
FLATLEY JAY TDirectorDec 12Sale334.133,3001,102,629371,559Dec 13 07:26 PM
OSTADAN OMEADEVP Ops, Products, StrategyDec 10Sale321.50644207,04621,613Dec 12 01:59 PM
Stapley MarcEVP Strategy & Corp DevelopmtDec 06Sale329.691,000329,6956,957Dec 07 05:17 PM
EPSTEIN ROBERT SDirectorDec 03Option Exercise51.171,00051,1706,101Dec 04 09:03 PM
EPSTEIN ROBERT SDirectorDec 03Sale343.571,345462,1024,756Dec 04 09:03 PM
Dadswell CharlesSr VP & General CounselDec 03Sale343.57566194,4615,606Dec 04 09:01 PM
deSouza Francis APresident and CEODec 03Sale345.903,0001,037,68863,643Dec 04 09:02 PM
FLATLEY JAY TDirectorNov 28Sale321.803,3001,061,940373,410Nov 30 04:24 PM
OSTADAN OMEADEVP Ops, Products, StrategyNov 23Sale306.74644197,54122,257Nov 27 04:39 PM
FLATLEY JAY TDirectorNov 14Sale312.503,3001,031,250376,710Nov 16 04:09 PM
Ronaghi MostafaSr VP & CTONov 12Option Exercise37.0410,000370,40079,612Nov 14 05:44 PM
Ronaghi MostafaSr VP & CTONov 12Sale314.6310,0003,146,33769,612Nov 14 05:44 PM
Stapley MarcEVP Strategy & Corp DevelopmtNov 07Sale336.681,000336,6806,957Nov 09 04:23 PM
Van Oene MarkSVP Chief Commercial OfficerNov 05Option Exercise29.446,000176,64017,126Nov 07 05:05 PM
Van Oene MarkSVP Chief Commercial OfficerNov 05Sale326.116,8352,228,95010,291Nov 07 05:05 PM
EPSTEIN ROBERT SDirectorNov 01Option Exercise51.171,00051,1706,447Nov 02 05:01 PM
deSouza Francis APresident and CEONov 01Sale310.852,100652,78870,235Nov 02 05:03 PM
EPSTEIN ROBERT SDirectorNov 01Sale311.861,346419,7645,101Nov 02 05:01 PM
FLATLEY JAY TDirectorOct 24Sale310.583,3001,024,914382,304Oct 26 04:35 PM
Ronaghi MostafaSr VP & CTOOct 10Option Exercise37.0410,000370,40080,805Oct 12 04:37 PM
Ronaghi MostafaSr VP & CTOOct 10Sale311.8410,0003,118,42470,805Oct 12 04:37 PM
FLATLEY JAY TDirectorOct 10Sale321.583,3001,061,214385,604Oct 12 04:35 PM
EPSTEIN ROBERT SDirectorOct 01Option Exercise51.171,00051,1706,793Oct 03 04:17 PM
deSouza Francis APresident and CEOOct 01Sale369.612,100776,18372,335Oct 03 04:20 PM
EPSTEIN ROBERT SDirectorOct 01Sale369.151,346496,8765,447Oct 03 04:17 PM
FLATLEY JAY TDirectorSep 26Sale360.813,3001,190,673388,904Sep 28 05:29 PM
FLATLEY JAY TDirectorSep 12Sale351.663,3001,160,478392,204Sep 14 09:25 PM
Ronaghi MostafaSr VP & CTOSep 10Option Exercise37.0410,000370,40080,805Sep 11 05:49 PM
Ronaghi MostafaSr VP & CTOSep 10Sale347.0710,0003,470,70970,805Sep 11 05:49 PM
EPSTEIN ROBERT SDirectorSep 07Option Exercise51.171,00051,1707,139Sep 11 05:45 PM
EPSTEIN ROBERT SDirectorSep 07Sale345.141,346464,5585,793Sep 11 05:45 PM
deSouza Francis APresident and CEOSep 04Sale353.662,100742,68674,435Sep 06 06:26 PM
Van Oene MarkSVP Chief Commercial OfficerSep 04Sale354.181,091386,41011,126Sep 06 06:09 PM
Stapley MarcEVP Strategy & Corp DevelopmtSep 04Sale352.051,000352,0548,516Sep 06 08:22 PM
Ronaghi MostafaSr VP & CTOAug 10Option Exercise37.0410,000370,40080,805Aug 14 04:07 PM
Ronaghi MostafaSr VP & CTOAug 10Sale331.3910,0003,313,86170,805Aug 14 04:07 PM
OSTADAN OMEADEVP Ops, Products, StrategyAug 02Sale320.701,334427,81424,484Aug 06 08:11 PM
Stapley MarcEVP Strategy & Corp DevelopmtAug 02Sale324.801,000324,7987,516Aug 06 08:10 PM
deSouza Francis APresident and CEOAug 01Sale327.412,100687,55576,535Aug 03 03:03 PM
EPSTEIN ROBERT SDirectorJul 23Sale311.15500155,5756,139Jul 24 07:21 PM
deSouza Francis APresident and CEOJul 12Sale300.003,300990,00078,635Jul 13 02:39 PM
Ronaghi MostafaSr VP & CTOJul 10Option Exercise37.047,500277,80078,496Jul 12 07:39 PM
Ronaghi MostafaSr VP & CTOJul 10Sale288.897,5002,166,70170,996Jul 12 07:39 PM
deSouza Francis APresident and CEOJul 02Sale276.142,100579,88782,271Jul 03 06:20 PM
EPSTEIN ROBERT SDirectorJun 21Sale288.45500144,2256,639Jun 22 07:12 PM
Ronaghi MostafaSr VP & CTOJun 11Option Exercise28.4510,500298,72581,496Jun 13 06:21 PM
Stapley MarcEVP Strategy & Corp DevelopmtJun 11Sale285.181,446412,3648,516Jun 13 06:24 PM
Ronaghi MostafaSr VP & CTOJun 11Sale284.8310,5002,990,75970,996Jun 13 06:21 PM
OSTADAN OMEADEVP Ops, Products, StrategyJun 01Sale274.611,335366,60425,818Jun 04 08:57 PM
deSouza Francis APresident and CEOJun 01Sale272.912,100573,10784,371Jun 04 08:54 PM
EPSTEIN ROBERT SDirectorMay 21Sale271.00500135,5006,588May 22 05:25 PM
EASTHAM KARINDirectorMay 21Sale269.801,000269,80212,288May 22 05:23 PM
Ronaghi MostafaSr VP & CTOMay 16Option Exercise28.4510,000284,50080,996May 18 07:39 PM
Ronaghi MostafaSr VP & CTOMay 16Sale267.7110,0002,677,13570,996May 18 07:39 PM
FLATLEY JAY TDirectorMay 14Sale268.001,460391,2804,000May 16 09:40 PM
deSouza Francis APresident and CEOMay 14Sale268.632,100564,12486,471May 16 09:37 PM
OSTADAN OMEADEVP Ops, Products, StrategyMay 02Sale242.601,314318,77627,153May 04 06:53 PM
BOWMAN A BLAINEDirectorMay 01Option Exercise55.143,000165,42619,868May 03 06:23 PM
BOWMAN A BLAINEDirectorMay 01Sale241.453,000724,33616,868May 03 06:23 PM